Tower Research Capital LLC TRC cut its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON – Get Rating) by 55.9% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 4,028 shares of the biotechnology company’s stock after selling 5,116 shares during the quarter. Tower Research Capital LLC TRC’s holdings in Axon Enterprise were worth $466,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds and other institutional investors have also bought and sold shares of the company. Capital International Investors lifted its holdings in shares of Axon Enterprise by 605.2% during the 1st quarter. Capital International Investors now owns 2,660,634 shares of the biotechnology company’s stock worth $366,449,000 after acquiring an additional 2,283,343 shares during the last quarter. William Blair Investment Management LLC lifted its stake in Axon Enterprise by 22.2% during the second quarter. William Blair Investment Management LLC now owns 2,130,903 shares of the biotechnology company’s stock worth $198,536,000 after purchasing an additional 386,861 shares during the last quarter. State Street Corp boosted its holdings in shares of Axon Enterprise by 13.3% in the 1st quarter. State Street Corp now owns 2,220,692 shares of the biotechnology company’s stock worth $305,856,000 after purchasing an additional 261,508 shares in the last quarter. Allianz Asset Management GmbH increased its position in shares of Axon Enterprise by 125.9% during the 2nd quarter. Allianz Asset Management GmbH now owns 243,466 shares of the biotechnology company’s stock valued at $22,683,000 after purchasing an additional 135,696 shares during the last quarter. Finally, Sei Investments Co. raised its holdings in shares of Axon Enterprise by 586.5% during the 2nd quarter. Sei Investments Co. now owns 147,653 shares of the biotechnology company’s stock valued at $13,757,000 after buying an additional 126,144 shares in the last quarter. Hedge funds and other institutional investors own 75.62% of the company’s stock.
Axon Enterprise Price Performance
Shares of AXON stock opened at $193.55 on Friday. The company has a debt-to-equity ratio of 0.01, a quick ratio of 2.39 and a current ratio of 2.79. The firm has a market cap of $13.77 billion, a P/E ratio of 133.48 and a beta of 0.84. The business’s 50 day moving average price is $183.20 and its 200-day moving average price is $156.96. Axon Enterprise, Inc. has a fifty-two week low of $82.49 and a fifty-two week high of $204.99.
Wall Street Analysts Forecast Growth
A number of research analysts have commented on the stock. Raymond James cut shares of Axon Enterprise from a “strong-buy” rating to an “outperform” rating and set a $223.00 price target on the stock. in a research report on Friday, February 17th. Needham & Company LLC lifted their target price on shares of Axon Enterprise from $200.00 to $240.00 in a research report on Wednesday, January 25th. JMP Securities raised their price objective on Axon Enterprise from $195.00 to $235.00 and gave the company a “market outperform” rating in a research note on Wednesday, February 1st. Morgan Stanley lifted their price objective on Axon Enterprise from $130.00 to $155.00 and gave the stock an “equal weight” rating in a report on Tuesday, December 13th. Finally, Credit Suisse Group increased their target price on Axon Enterprise from $152.00 to $200.00 and gave the company an “outperform” rating in a report on Tuesday, January 10th. Two analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $195.00.
Insider Activity at Axon Enterprise
In other Axon Enterprise news, CEO Patrick W. Smith sold 71,499 shares of the company’s stock in a transaction on Tuesday, January 17th. The shares were sold at an average price of $185.77, for a total value of $13,282,369.23. Following the completion of the transaction, the chief executive officer now directly owns 2,254,734 shares in the company, valued at approximately $418,861,935.18. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Axon Enterprise news, CEO Patrick W. Smith sold 71,499 shares of the company’s stock in a transaction that occurred on Tuesday, January 17th. The stock was sold at an average price of $185.77, for a total transaction of $13,282,369.23. Following the transaction, the chief executive officer now owns 2,254,734 shares in the company, valued at approximately $418,861,935.18. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Patrick W. Smith sold 1,300 shares of the firm’s stock in a transaction that occurred on Thursday, January 19th. The shares were sold at an average price of $185.06, for a total value of $240,578.00. Following the completion of the transaction, the chief executive officer now owns 2,279,570 shares of the company’s stock, valued at approximately $421,857,224.20. The disclosure for this sale can be found here. Insiders have sold a total of 351,128 shares of company stock worth $66,165,548 over the last quarter. Corporate insiders own 6.90% of the company’s stock.
Axon Enterprise Company Profile
Axon Enterprise, Inc engages in the development, manufacture, and sale of conducted electrical weapons for personal defense. It operates through the TASER segment and Software and Sensors segment. The TASER segment sells conducted electrical weapons, accessories, and other related products and services.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Axon Enterprise, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Axon Enterprise wasn’t on the list.
While Axon Enterprise currently has a “Moderate Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.
